Brief: Biolidics Says Got Authorisation From Indonesia For Clearepi Antigen Rapid Test Kit
March 15 (Reuters) - Biolidics Ltd BIOL.SI :
* GOT PRODUCT AUTHORISATION FROM INDONESIA FOR CLEAREPI
ANTIGEN
RAPID TEST KIT
* AUTHORISATION REMAINS VALID UNTIL 10 MARCH 2022
* AUTHORISATION IS EXPECTED TO CONTRIBUTE POSITIVELY TO
REVENUE OF
GROUP FOR CURRENT FINANCIAL YEAR ENDING 31 DECEMBER 2021
Source text for Eikon: urn:newsml:reuters.com:*:nSNZ7d5gn0
Further company coverage: BIOL.SI
(Reuters.Briefs@thomsonreuters.com)
Recent news on Embracing Future Holdings
See all newsBrief: Embracing Future To Buy 10% Of Embracing Future Biomedical For S$6.7 Million
Brief: Biolidics Posts FY Pretax Profit SGD -3.187 Million
Brief: Biolidics Ltd To Acquire Shenzhen Xiaozhao Network Technology
Brief: Biolidics Announces Resignation Of Song Tang Yih As Executive Director And CEO
Brief: Biolidics Announces Cybersecurity Incident